abstract |
Provided are Syk inhibitors and methods of use thereof. Specifically, the present invention provides a quinolinone represented by formula (I), a quinazolinone derivative, or a pharmaceutically acceptable salt thereof, a method for producing the same, a pharmaceutical composition, and use thereof in a therapeutic agent for a Syk receptor-related disease. [Chemical 1] |